Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyMon, 22 Jul 2024 16:22:23 +0200Tue, 12 Mar 2024 16:16:00 +0100Human medicines European public assessment report (EPAR): Pomalidomide Viatris, pomalidomide, Date of authorisation: 16/02/2024, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/pomalidomide-viatrisHuman medicines European public assessment report (EPAR): Pomalidomide Viatris, pomalidomide, Date of authorisation: 16/02/2024, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/pomalidomide-viatrisTue, 12 Mar 2024 16:16:00 +0100Human medicinePomalidomide Viatris : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-6195-en.pdfPomalidomide Viatris : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-6195-en.pdfTue, 12 Mar 2024 15:56:18 +0100Human medicine